Key terms

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATRC news

Yesterday 12:25pm ET Oppenheimer medical devices analysts hold analyst/industry conference call by TipRanks Yesterday 4:55am ET Oppenheimer medical devices analysts hold analyst/industry conference call by TipRanks Apr 11 4:46pm ET Oppenheimer medical devices analysts hold analyst/industry conference call by TipRanks Feb 16 8:52am ET AtriCure price target lowered to $42 from $50 at Stifel by TipRanks Feb 16 8:07am ET Stifel Nicolaus Remains a Buy on Atricure (ATRC) by TipRanks Feb 16 7:57am ET Oppenheimer Sticks to Its Hold Rating for Atricure (ATRC) by TipRanks Feb 16 7:34am ET Atricure’s Strong Growth and Positive 2024 Outlook Merit a Buy Rating by TipRanks Feb 16 7:28am ET AtriCure price target raised to $57 from $52 at Canaccord by TipRanks Feb 16 7:27am ET Atricure’s Strong Growth and Market Position Justify Buy Rating and $65 Target Price by TipRanks Feb 16 7:20am ET Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV) by TipRanks Feb 16 7:18am ET AtriCure price target raised to $58 from $57 at UBS by TipRanks Feb 16 5:55am ET Atricure’s Strong Performance and Growth Potential Merit a Buy Rating by TipRanks Feb 16 2:10am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Feb 15 4:04pm ET AtriCure sees FY24 EPS (82c) to (74c), consensus (69c) by TipRanks Feb 15 4:03pm ET AtriCure reports Q4 EPS (21c), consensus (23c) by TipRanks Jan 22 7:01am ET AtriCure price target raised to $52 from $50 at Canaccord by TipRanks

No recent press releases are available for ATRC

ATRC Financials

1-year income & revenue

Key terms

ATRC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATRC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days